HK1218622A1 - 含有改性瓜尔胶的药物软明胶胶囊剂型 - Google Patents

含有改性瓜尔胶的药物软明胶胶囊剂型 Download PDF

Info

Publication number
HK1218622A1
HK1218622A1 HK16106609.2A HK16106609A HK1218622A1 HK 1218622 A1 HK1218622 A1 HK 1218622A1 HK 16106609 A HK16106609 A HK 16106609A HK 1218622 A1 HK1218622 A1 HK 1218622A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
guar gum
Prior art date
Application number
HK16106609.2A
Other languages
English (en)
Chinese (zh)
Inventor
Brendan Muldoon
Ryan Gerald LOUGHLIN
Gerarde SWEENEY
Emma Karen BOYD
Original Assignee
Warner Chilcott Company, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Company, Llc filed Critical Warner Chilcott Company, Llc
Publication of HK1218622A1 publication Critical patent/HK1218622A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16106609.2A 2013-03-15 2014-03-14 含有改性瓜尔胶的药物软明胶胶囊剂型 HK1218622A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794906P 2013-03-15 2013-03-15
US61/794,906 2013-03-15
PCT/US2014/027145 WO2014152269A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Publications (1)

Publication Number Publication Date
HK1218622A1 true HK1218622A1 (zh) 2017-03-03

Family

ID=50588879

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106609.2A HK1218622A1 (zh) 2013-03-15 2014-03-14 含有改性瓜尔胶的药物软明胶胶囊剂型

Country Status (14)

Country Link
US (3) US9795569B2 (enExample)
EP (2) EP3187170A1 (enExample)
JP (3) JP6335270B2 (enExample)
KR (1) KR20150131070A (enExample)
CN (2) CN111374959A (enExample)
AU (2) AU2014239994B2 (enExample)
BR (1) BR112015022946A8 (enExample)
CA (1) CA2906633C (enExample)
ES (1) ES2619121T3 (enExample)
HK (1) HK1218622A1 (enExample)
IL (1) IL241377B (enExample)
MX (2) MX364440B (enExample)
RU (1) RU2676480C2 (enExample)
WO (1) WO2014152269A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX364440B (es) * 2013-03-15 2019-04-26 Warner Chilcott Co Llc Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.
CA2980165C (en) * 2015-03-26 2021-06-15 Patheon Softgels Inc. Liquisoft capsules
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
CN116916895A (zh) * 2020-11-13 2023-10-20 辉瑞公司 他拉唑帕尼软明胶胶囊剂型
KR20230107647A (ko) * 2020-11-13 2023-07-17 화이자 인코포레이티드 탈라조파립 연질 젤라틴 캡슐 투여 형태
CN116531444B (zh) * 2023-07-06 2023-10-10 健码制药（广东）有限公司 镇咳清肺软胶囊及其制备工艺

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5989535A (en) 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
IN188719B (enExample) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
FR2843304B1 (fr) * 2002-08-07 2005-12-16 Ricarimpex Extraits de sangsues pour stents
EP1599485A2 (en) 2003-02-18 2005-11-30 Ranbaxy Laboratories, Ltd. Podophyllotoxin derivatives as antitumor agents
KR100570450B1 (ko) * 2003-09-25 2006-04-12 한국유나이티드제약 주식회사 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
WO2005070949A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
EP1709061A1 (en) 2004-01-15 2006-10-11 Warner Chilcott Company Inc. Di-steroidal prodrugs of ethinyl estradiol
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
US10016442B2 (en) 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
CA2610481A1 (en) 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
CN101218245B (zh) 2005-07-12 2011-08-17 沃纳奇尔科特有限责任公司 炔雌醇的3-酯前药
US7468970B2 (en) 2005-10-24 2008-12-23 Honeywell International Inc. Routing of mobile agents in a network
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20070104778A1 (en) 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
WO2007066837A1 (en) 2005-12-06 2007-06-14 Lg Household & Health Care Ltd. Delivery system for tooth whitening component using in situ gelling
EP1986591A1 (en) 2006-02-10 2008-11-05 LG Household & Health Care Ltd. In-situ melting and gelling tablet composition for oral care
US20080090569A1 (en) 2006-10-13 2008-04-17 At&T Knowledge Ventures, L.P. Method and apparatus for performing signal processing in an ip multimedia subsystem network
US20080122993A1 (en) 2006-11-29 2008-05-29 Sanyo Electric Co., Ltd. Television image receiver
EP2114380A1 (en) 2007-01-25 2009-11-11 Panacea Biotec Ltd. Modified release pharmaceutical composition and a process of making the same
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles
EP2264574A2 (en) 2008-03-26 2010-12-22 Crucialtec Co., Ltd. Optical pointing apparatus and portable electronic apparatus with the same
CN101474167A (zh) * 2009-01-23 2009-07-08 西安德天药业股份有限公司 雌二醇阴道用胶囊的制备方法
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
MX364440B (es) * 2013-03-15 2019-04-26 Warner Chilcott Co Llc Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.

Also Published As

Publication number Publication date
US20140271838A1 (en) 2014-09-18
US10744096B2 (en) 2020-08-18
JP6335270B2 (ja) 2018-05-30
CA2906633A1 (en) 2014-09-25
CA2906633C (en) 2021-11-30
MX364440B (es) 2019-04-26
NZ712280A (en) 2021-01-29
US20150044285A1 (en) 2015-02-12
JP2020147569A (ja) 2020-09-17
JP2016513684A (ja) 2016-05-16
AU2014239994A1 (en) 2015-10-08
WO2014152269A1 (en) 2014-09-25
CN105307634B (zh) 2020-03-10
IL241377B (en) 2019-08-29
CN111374959A (zh) 2020-07-07
JP2018140998A (ja) 2018-09-13
MX2015012057A (es) 2016-05-05
US20180036252A1 (en) 2018-02-08
RU2015137612A (ru) 2017-04-24
BR112015022946A8 (pt) 2022-11-29
EP2950781B1 (en) 2016-12-21
US9795569B2 (en) 2017-10-24
IL241377A0 (en) 2015-11-30
MX2019004554A (es) 2019-08-05
RU2676480C2 (ru) 2018-12-29
ES2619121T3 (es) 2017-06-23
CN105307634A (zh) 2016-02-03
BR112015022946A2 (pt) 2017-07-18
AU2019200116A1 (en) 2019-01-31
KR20150131070A (ko) 2015-11-24
JP6704430B2 (ja) 2020-06-03
AU2014239994B2 (en) 2019-01-24
US9820946B2 (en) 2017-11-21
EP3187170A1 (en) 2017-07-05
EP2950781A1 (en) 2015-12-09

Similar Documents

Publication Publication Date Title
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
MX2015011163A (es) Capsula entericas blandas que no contienen gelatina.
AU2013317899A8 (en) Biodegradable microcapsules containing filling material
MX2015008069A (es) Conjunto de envasado para dispositivos de administracion de farmacos.
EP3384891A4 (en) MEDICAMENT CARTET, DRUG DELIVERY AND MEDICAMENT PACKAGING DEVICE
GEP20217243B (en) Orodispersible dosage unit containing an estetrol component
PE20181095A1 (es) Envase blister
EP3182953A4 (en) Medication packaging and dose regimen system
MX2016003754A (es) Una composicion farmaceutica estable que contiene amlodipina y valsartan.
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
HK1220113A1 (zh) 药物软明胶胶囊剂型
EP3318217A4 (en) PROTHESIS PACKAGING, PROSTHESIS AND PROSTHESIS WITH PACKAGING
HK1249442A1 (zh) 具有改善的储存稳定性的药物组合物及其制备方法
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
HK1249441A1 (zh) 具有改善的储存稳定性的药物组合物及其制备方法
HK1249440A1 (zh) 具有改善的储存稳定性的药物组合物及其制备方法
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
GB2576446B (en) Shape memory alloy based drug delivery device
IN2013MU02015A (enExample)
王娟 The Contrastive Multimodal Study between Chinese and Western Movie Posters
林静 et al. A General Description for Chinese Medicine in Treating Premature Ovarian Failure
IN2013CH04473A (enExample)
PT3623311T (pt) Processo de produção de uma rolha capsulada